ELRIG Strengthens Leadership with New Scientific Advisory Board Members
Wednesday, 22 July 2026, 16:59
New Appointments to the Scientific Advisory Board
ELRIG, a not-for-profit drug discovery organization, has recently appointed Dr Hitesh Sanganee and Dr Marcus Schindler to its Scientific Advisory Board. This strategic move is set to enrich ELRIG's initiatives in the field of drug discovery.
Background of the New Members
- Dr Hitesh Sanganee brings extensive experience in research and development from top pharmaceutical companies.
- Dr Marcus Schindler has a notable track record in venture capital investing in biotech startups.
Impact on ELRIG's Mission
By integrating the expertise of these seasoned professionals, ELRIG aims to accelerate its mission to improve drug development processes and facilitate innovative solutions in the biotech sector.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.